Automotive InnovationGM's LMR Battery Breakthrough Could Reshape EV Cost Economics and Stock ValuationsFeb 18, 2026
CommoditiesPentagon's 2027 REE Ban Reshapes Supply Chains as North American Producers Race to Fill the GapFeb 18, 2026
Technology StocksPlanet Labs' SunCatcher Satellite Program Signals AI-Powered Space Tech Is Becoming a Real Revenue StoryFeb 18, 2026
Healthcare EquitiesGSK's Depemokimab Targets Late 2027 Launch: What Investors Need to Know About the Ultra-Long-Acting Biologic BetFeb 18, 2026
CommoditiesDPM Metals' Čoka Rakita Mine Reaches First Ore Milestone, Adding 148,000 Oz/Year to Global Gold SupplyFeb 18, 2026
CommoditiesArtemis Gold's Blackwater Mine Expansion Targets Half-Million Ounce Production by 2029, Signaling Major Supply ShiftFeb 18, 2026
Automotive SectorFord Ditches EV Plans at BlueOval City, Bets on Gas Trucks to Drive ProfitsFeb 18, 2026
Biotech EquitiesCellectis Eyes $700M Peak Sales as Lasme-cel BLA Filing Sets Up Pivotal FDA Catalyst for CLLSFeb 18, 2026
Corporate Actions & EarningsAegon's $350M US Relocation Bet: What the Move to Transamerica Inc. Means for TradersFeb 18, 2026
Automotive SectorFord Pivots From Electric to Gas and Hybrid Vans, Signaling a Market Reality Check for EV AmbitionsFeb 18, 2026
Healthcare SectorPharma Giants Double Down on Oncology: Acquisitions and FDA Wins Reshape Cancer Drug Investment LandscapeFeb 17, 2026
Earnings & GuidanceBroadcom Stock Surges on $21B AI Infrastructure Order Backlog, Signaling Semiconductor Sector ShiftFeb 16, 2026
AnalysisMicrosoft's Enterprise AI Surge Exposes Infrastructure Bottlenecks as Competitors Rush to AdaptFeb 15, 2026
AnalysisFour Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near MarketFeb 15, 2026
AnalysisFour Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research CycleFeb 15, 2026
AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsFeb 15, 2026
AnalysisBroadcom Emerges as Critical AI Infrastructure Provider With $21B in Custom Chip OrdersFeb 15, 2026
Biotech & Pharma StocksPrecision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory MilestonesFeb 15, 2026
